Everything you need to know about the selective growth hormone-releasing peptide
Ipamorelin is a selective growth hormone-releasing peptide (GHRP) and the first synthetic GHRP with a selective mechanism of action. Discovered through research on the ghrelin receptor, it provides growth hormone stimulation with minimal side effects.
What makes Ipamorelin unique is its selectivity - it stimulates GH release without significantly affecting cortisol, prolactin, or TSH levels, making it ideal for research protocols requiring clean data without interference from other hormonal pathways.
Binds to and activates the growth hormone secretagogue receptor, stimulating GH release from the pituitary.
Stimulates growth hormone secretion in a dose-dependent manner, with maximal effects at higher doses.
Unlike other GHRPs, Ipamorelin does not significantly stimulate ACTH, cortisol, or prolactin release.
Works synergistically with GHRH analogs like CJC-1295 for enhanced GH stimulation.
Research Use Only: This product is intended exclusively for laboratory research purposes. Not for human consumption. All research must be conducted in controlled laboratory settings by qualified personnel in accordance with applicable laws and regulations.
